关注
Van Morris
Van Morris
在 mdanderson.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
Encorafenib, Binimetinib, and Cetuximab in BRAF V600E–Mutated Colorectal Cancer
S Kopetz, A Grothey, R Yaeger, E Van Cutsem, J Desai, T Yoshino, ...
New England Journal of Medicine 381 (17), 1632-1643, 2019
12742019
Phase II pilot study of vemurafenib in patients with metastatic BRAF-mutated colorectal cancer
S Kopetz, J Desai, E Chan, JR Hecht, PJ O'Dwyer, D Maru, V Morris, ...
Journal of clinical oncology 33 (34), 4032, 2015
7392015
Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study
VK Morris, ME Salem, H Nimeiri, S Iqbal, P Singh, K Ciombor, B Polite, ...
The Lancet Oncology 18 (4), 446-453, 2017
3922017
Classifying colorectal cancer by tumor location rather than sidedness highlights a continuum in mutation profiles and consensus molecular subtypes
JM Loree, AAL Pereira, M Lam, AN Willauer, K Raghav, A Dasari, ...
Clinical Cancer Research 24 (5), 1062-1072, 2018
3232018
Clinical and molecular characterization of early‐onset colorectal cancer
AN Willauer, Y Liu, AAL Pereira, M Lam, JS Morris, KPS Raghav, ...
Cancer 125 (12), 2002-2010, 2019
2882019
Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment
MP Morelli, MJ Overman, A Dasari, SMA Kazmi, T Mazard, E Vilar, ...
Annals of Oncology 26 (4), 731-736, 2015
2802015
ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper
A Dasari, VK Morris, CJ Allegra, C Atreya, AB Benson III, P Boland, ...
Nature reviews Clinical oncology 17 (12), 757-770, 2020
2722020
Phase IB Study of Vemurafenib in Combination with Irinotecan and Cetuximab in Patients with Metastatic Colorectal Cancer with BRAFV600E Mutation
DS Hong, VK Morris, B El Osta, AV Sorokin, F Janku, S Fu, MJ Overman, ...
Cancer discovery 6 (12), 1352-1365, 2016
2342016
Anti-EGFR-resistant clones decay exponentially after progression: implications for anti-EGFR re-challenge
CM Parseghian, JM Loree, VK Morris, X Liu, KK Clifton, S Napolitano, ...
Annals of Oncology 30 (2), 243-249, 2019
1992019
Randomized trial of irinotecan and cetuximab with or without vemurafenib in BRAF-mutant metastatic colorectal cancer (SWOG 1406).
S Kopetz, SL McDonough, VK Morris, HJ Lenz, AM Magliocco, CE Atreya, ...
Journal of Clinical Oncology 35 (4_suppl), 520-520, 2017
1952017
Randomized trial of irinotecan and cetuximab with or without vemurafenib in BRAF-mutant metastatic colorectal cancer (SWOG S1406)
S Kopetz, KA Guthrie, VK Morris, HJ Lenz, AM Magliocco, D Maru, Y Yan, ...
Journal of Clinical Oncology 39 (4), 285, 2021
1902021
Treatment of metastatic colorectal cancer: ASCO guideline
VK Morris, EB Kennedy, NN Baxter, AB Benson III, A Cercek, M Cho, ...
Journal of clinical oncology: official journal of the American Society of …, 2023
1692023
Progression-free survival remains poor over sequential lines of systemic therapy in patients with BRAF-mutated colorectal cancer
V Morris, MJ Overman, ZQ Jiang, C Garrett, S Agarwal, C Eng, B Kee, ...
Clinical colorectal cancer 13 (3), 164-171, 2014
1442014
Association of CpG island methylator phenotype and EREG/AREG methylation and expression in colorectal cancer
MS Lee, EJ McGuffey, JS Morris, G Manyam, V Baladandayuthapani, ...
British journal of cancer 114 (12), 1352-1361, 2016
972016
Association between KRAS mutation and lung metastasis in advanced colorectal cancer
AAL Pereira, JFM Rego, V Morris, MJ Overman, C Eng, CR Garrett, ...
British journal of cancer 112 (3), 424-428, 2015
962015
Randomized trial of irinotecan and cetuximab with or without vemurafenib in BRAF-mutant metastatic colorectal cancer (SWOG S1406).
S Kopetz, SL McDonough, HJ Lenz, AM Magliocco, CE Atreya, LA Diaz, ...
Journal of Clinical Oncology 35 (15_suppl), 3505-3505, 2017
832017
Pathological tumor response following immune checkpoint blockade for deficient mismatch repair advanced colorectal cancer
K Ludford, R Cohen, M Svrcek, WC Foo, R Colle, Y Parc, JV Thomas, ...
JNCI: Journal of the National Cancer Institute 113 (2), 208-211, 2021
692021
Comprehensive genomic profiling of metastatic squamous cell carcinoma of the anal canal
V Morris, X Rao, C Pickering, WC Foo, A Rashid, K Eterovic, T Kim, ...
Molecular Cancer Research 15 (11), 1542-1550, 2017
692017
FBXW7 missense mutation: a novel negative prognostic factor in metastatic colorectal adenocarcinoma
K Korphaisarn, VK Morris, MJ Overman, DR Fogelman, BK Kee, ...
Oncotarget 8 (24), 39268, 2017
662017
MET amplification in metastatic colorectal cancer: an acquired response to EGFR inhibition, not a de novo phenomenon
K Raghav, V Morris, C Tang, P Morelli, HM Amin, K Chen, GC Manyam, ...
Oncotarget 7 (34), 54627, 2016
622016
系统目前无法执行此操作,请稍后再试。
文章 1–20